Giordana Mahn to Speak at MedStartr’s Healthcare Innovators Club Event
Building a medical device requires an immense amount of regulatory compliance and intellectual property (IP) protection strategies, and Associate Giordana Mahn will be providing insight at a MedStartr Healthcare Innovators Club event discussing the process of protecting IP for medical devices.
Date and Time: Wednesday, June 16 at 1 p.m. Central
Event Name: Protect Your Med Device Intellectual Property
Join Giordana for the discussion on Clubhouse here.
Dr. Ediuska Laurens, Alex Fair, and Katrina Rogers will be joining Giordana for this discussion, which will include insight on the following:
- Disclosure and timing issues for obtaining both FDA approval and IP rights
- Intersection between patent law and 510k submission
- Advice when deciding to seek patent protection on technology
- Advice when deciding to seek patent protection on software or AI inventions
- Challenges surrounding the Alice decision
- IP vs. trade secrets
- IP assets that need protection in each stage of the medical device life cycle
Giordana secures valuable patent rights for a variety of clients in the mechanical, biomechanical, electromechanical, consumer products, and medical device fields. With significant experience in foreign and domestic patent prosecution, as well as post-grant proceedings, she likes to say she “can prosecute anything with moving parts.” She also helps clients manage their global IP portfolios and provides day-to-day counseling on invalidity, non-infringement, freedom-to-practice and other business-critical IP matters.
MedStartr is all about driving innovation further faster in healthcare. The goal of the myriad conversations it enables is to not only talk about innovation but to do things, to get involved, to create the future of medicine together. To this end, MedStartr.com is a crowdfunding platform designed for healthcare startups. It isn’t just for funding but for bringing patients, care team members, partners, pilots, and investors to the table for early-stage companies, non-profits, and people with innovative ideas.